Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Garg Vipin K Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Granted 126 shares @ $2.81, valued at $354.1
02/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Granted 1,938 shares @ $10.2085, valued at $19.8k
Paid exercise price by delivering 7,658 shares @ $13.78, valued at $105.5k
Exercised 16,546 restricted stock units @ $0
02/01/2023 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Granted 302,900 options to buy @ $12.88, valued at $3.9M
Granted 107,100 restricted stock units @ $0
12/01/2022 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 3,007 shares @ $9.95, valued at $29.9k
10/03/2022 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 3,008 shares @ $12.77, valued at $38.4k
09/01/2022 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 3,007 shares @ $18.94, valued at $57k
Sold 20,000 shares @ $20.0161, valued at $400.3k
08/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2022 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 3,007 shares @ $6.05, valued at $18.2k
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2022 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 2,355 shares @ $7.2, valued at $17k
01/03/2022 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 3,007 shares @ $8.93, valued at $26.9k
12/01/2021 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 3,007 shares @ $10.49, valued at $31.5k
11/01/2021 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 3,007 shares @ $10.8, valued at $32.5k
10/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/31/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2021 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 3,007 shares @ $9.07, valued at $27.3k
07/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2020 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 2,243 shares @ $12.23, valued at $27.4k
11/02/2020 4 Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 2,015 shares @ $11.45, valued at $23.1k
10/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/31/2020 4 Garg Vipin K (President & CEO) has filed a Form 4 on Altimmune, Inc.
Txns: Paid exercise price by delivering 2,015 shares @ $17.62, valued at $35.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy